Avi Novick
Analyst
Morgan Stanley
Equibles does not estimate personal net worth.
About Avi Novick
Avi Novick is recorded as Analyst at Morgan Stanley. Avi Novick has spoken on 3 earnings calls across 1 company, most recently for Vir Biotechnology, Inc. on August 6, 2025. The companies whose calls Avi Novick spoke on are classified in the Healthcare sector.
Avi Novick on recent calls
“Yeah, so I guess just on HDV, could you perhaps give us a little bit of enrollment update on the Eclipse programs? particularly for Eclipse I. And then this might be a little bit premature, but, you know, I guess as we think about the TAM and HDV, can you tell us about any sort of prep work or thoughts on, you know…”
“So a competitor of yours recently shared updated data from its TCE-PSMA targeting program in metastatic CRPC.”
“So I guess number one on 5525, given the strong safety profile you've seen in the Phase I studies of 5818 and 5500, do you see a read through to 5525, And do you believe you can possibly more aggressively escalate doses in the upcoming Phase I study?”
Affiliation history
-
Morgan Stanley
Analyst
Transcript header (unverified)
Current